Today: September 09, 2024
Today: September 09, 2024

Investors' comments on global stocks rout

A passerby walks past in front of an electronic screen displaying the graph showing today's movements of Japan's Nikkei share average in Tokyo
August 05, 2024
Reuters

(Reuters) -Share markets around the world tumbled and bonds rallied on Monday as fears the United States could be heading for recession sent investors rushing from risk assets while wagering interest rates will have to fall rapidly to rescue growth.

Read More

Related

Business|Economy|News|Technology

Google faces new antitrust trial after ruling declaring search engine a monopoly

One month after a judge declared Google’s search engine an illegal monopoly, the tech giant is defending against another antitrust lawsuit that threatens to break up the company

Google faces new antitrust trial after ruling declaring search engine a monopoly
Americas|Business|Economy|Finance

Column-US inflation may soon undershoot Fed's 2% target: McGeever

After grappling with the strongest U.S. price pressures in four decades, it's hard for investors to adjust to the notion that inflation could soon

Column-US inflation may soon undershoot Fed's 2% target: McGeever
Business|Finance

US SEC hits 7 public companies with penalties for violating whistleblower protections

Seven public companies agreed to pay a combined $3 million to settle U.S.

US SEC hits 7 public companies with penalties for violating whistleblower protections
Business|Economy|Europe

Germany's competitiveness must become priority, finance minister says

Germany's economic competitiveness must become a political priority because citizens worry about their economic future and are looking towards political alternatives, Finance

Germany's competitiveness must become priority, finance minister says
Business|Health|Science

MBX Biosciences seeks up to $482.5 million valuation in US IPO

MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic disorders, including obesity, said on Monday it was seeking a valuation of up to $482.5 million

MBX Biosciences seeks up to $482.5 million valuation in US IPO
Share This

Popular

Business|Finance

Citi CFO expects investment banking fees to rise 20% in third quarter

Citi CFO expects investment banking fees to rise 20% in third quarter
Business|Economy|Europe

Main elements of Draghi competitiveness report

Main elements of Draghi competitiveness report
Business|Economy|News

Tariffs tend to hit the poor harder, WTO says

Tariffs tend to hit the poor harder, WTO says
Business|News|Opinion|Political

Trump says he will vote to legalize adult recreational marijuana use in Florida

Trump says he will vote to legalize adult recreational marijuana use in Florida